Please use this identifier to cite or link to this item:
Title: Management of multiple myeloma in asia: Resource-stratified guidelines
Authors: Tan, D.
Chng, W.J. 
Chou, T.
Nawarawong, W.
Hwang, S.-Y.
Chim, C.S.
Chen, W.
Durie, B.G.M.
Lee, J.H.
Issue Date: Nov-2013
Citation: Tan, D., Chng, W.J., Chou, T., Nawarawong, W., Hwang, S.-Y., Chim, C.S., Chen, W., Durie, B.G.M., Lee, J.H. (2013-11). Management of multiple myeloma in asia: Resource-stratified guidelines. The Lancet Oncology 14 (12) : e571-e581. ScholarBank@NUS Repository.
Abstract: Treatment of multiple myeloma has undergone substantial developments in the past 10 years. The introduction of novel drugs has changed the treatment of the disease and substantially improved survival outcomes. Clinical practice guidelines based on evidence have been developed to provide recommendations on standard treatment approaches. However, the guidelines do not take into account resource limitations encountered by developing countries. The huge disparities in economy, health-care infrastructure, and access to novel drugs in Asian countries hinder the delivery of optimum care to every patient with multiple myeloma in Asia. In this Review we outline the guidelines that correspond with different levels of health-care resources and expertise, with the aim to unify diagnostic and therapeutic guidelines and help with the design of future studies in Asia. © 2013 Elsevier Ltd.
Source Title: The Lancet Oncology
ISSN: 14702045
DOI: 10.1016/S1470-2045(13)70404-2
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.


checked on Jun 8, 2021


checked on Jun 8, 2021

Page view(s)

checked on Jun 6, 2021

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.